Nuzenio

Biophytis

Biophytis news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Biophytis Wins Brazilian Approval for Phase 2 Obesity Trial of BIO101 - TipRanksTipRanks · Mon, 10 Aug 2026 23:38:42 GMTBiophytis (BPTSY) wins ANVISA approval for multi-regional BIO101 obesity trial - Stock TitanStock Titan · Mon, 10 Aug 2026 21:18:40 GMTBIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY - BoursoramaBoursorama · Mon, 10 Aug 2026 05:00:00 GMTPrice performance - Yahoo Finance AustraliaYahoo Finance Australia · Thu, 06 Aug 2026 10:29:45 GMTBiophytis (BPTSY) 2025 loss €8.2m, low cash and going-concern uncertainty - Stock TitanStock Titan · Thu, 30 Jul 2026 15:33:02 GMT

Timeline

Mon, 10 Aug 2026 23:38:42 GMTBiophytis Wins Brazilian Approval for Phase 2 Obesity Trial of BIO101 - TipRanks
Mon, 10 Aug 2026 21:18:40 GMTBiophytis (BPTSY) wins ANVISA approval for multi-regional BIO101 obesity trial - Stock Titan
Mon, 10 Aug 2026 05:00:00 GMTBIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY - Boursorama
Thu, 06 Aug 2026 10:29:45 GMTPrice performance - Yahoo Finance Australia
Thu, 30 Jul 2026 15:33:02 GMTBiophytis (BPTSY) 2025 loss €8.2m, low cash and going-concern uncertainty - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biophytis.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.